
|Articles|February 17, 2021
New Cerba Research and Biokortex Partnership
Advertisement
Cerba Research has announced a new partnership with Biokortex to leverage patient biological and medical data to support drug developers and CROs with patient identification and recruitment activity.
The benefits of this new partnership include patients’ biological and medical data from over 25 million patients per year from over 1,000 sites located in Europe, Africa, and North America, a platform for screening and companion diagnostic testing across Europe and Africa, and more.
Click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Life Sciences Can’t Afford Fragmented Data and Disconnected Teams
2
ACT Brief: Rethinking Site Support in 2026, GSK’s New Severe Asthma Approval, and Priority Review Momentum in Multiple Myeloma
3
FDA Approves GSK’s Exdensur for Severe Asthma Based on SWIFT Phase III Data
4
ACT Brief: Neutral Tech Adoption at Sites, Scaling Unstructured Data for eSource, and Novo Nordisk’s CagriSema NDA
5




